Spectral AI Inc.

2.08
0.12 (6.12%)
At close: Jan 21, 2025, 3:59 PM
2.07
-0.24%
After-hours Jan 21, 2025, 07:45 PM EST
undefined%
Bid 2.06
Market Cap 44.10M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.63
PE Ratio (ttm) -3.29
Forward PE n/a
Analyst Buy
Ask 2.08
Volume 542,689
Avg. Volume (20D) 2,487,535
Open 1.97
Previous Close 1.96
Day's Range 1.96 - 2.10
52-Week Range 0.82 - 3.72
Beta undefined

About MDAI

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. ...

Sector Healthcare
IPO Date Apr 6, 2021
Employees 78
Stock Exchange NASDAQ
Ticker Symbol MDAI

Analyst Forecast

According to 3 analyst ratings, the average rating for MDAI stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 92.77% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Spectral AI Inc. is scheduled to release its earnings on Mar 26, 2025, during market hours.
Analysts project revenue of $6.83M, reflecting a 29.18% YoY growth and earnings per share of -0.14, making a -36.36% decrease YoY.
2 months ago
-11.26%
Spectral AI shares are trading lower. The company ... Unlock content with Pro Subscription
3 months ago
-3.36%
Spectral AI shares are trading higher after the company announced it named its founder Dr. J. Michael DiMaio as the Chairman.